Richie Kahn, MPH, is a health policy professional by training, clinical researcher by trade, and patient advisor by necessity. He is passionate about incorporating patient and caregiver perspectives into the clinical development process and ultimately reducing the time it takes to bring promising new therapeutics and diagnostics to market.

In this episode we discuss what clinical trials can learn from public health, the importance of community engagement and the ongoing role of technology in decentralized clinical trials.